Pure drug and polymer based nanotechnologies for the improved solubility, stability, bioavailability and targeting of anti-HIV drugs.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Advanced Drug Delivery Reviews

• Publication date

  2010-03-18

• Fields of study

  Medicine, Materials Science

• Identifiers
  DOI 10.1016/j.addr.2009.11.019PMID 19931328
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Enhancement of oral bioavailability of an HIV-attachment inhibitor by nanosizing and amorphous formulation approaches.

  2009cited by this paper
• Effects of nanomaterial physicochemical properties on in vivo toxicity.

  2009cited by this paper
• Targeted Delivery of PSC-RANTES for HIV-1 Prevention using Biodegradable Nanoparticles

  2009cited by this paper
• Up‐regulation of P‐glycoprotein by HIV protease inhibitors in a human brain microvessel endothelial cell line

  2009cited by this paper
• Nanomedicinal delivery approaches for therapeutic siRNA.

  2009cited by this paper
• The transport of anti-HIV drugs across blood–CNS interfaces: Summary of current knowledge and recommendations for further research

  2009cited by this paper
• Albumin nanoparticles targeted with Apo E enter the CNS by transcytosis and are delivered to neurones.

  2009cited by this paper
• Drug delivery systems in HIV pharmacotherapy: what has been done and the challenges standing ahead.

  2009cited by this paper
• Circulating Monocytes in HIV-1-Infected Viremic Subjects Exhibit an Antiapoptosis Gene Signature and Virus- and Host-Mediated Apoptosis Resistance1

  2009cited by this paper
• The Challenge of Finding a Cure for HIV Infection

  2009cited by this paper
• Controlled surface modification with poly(ethylene)glycol enhances diffusion of PLGA nanoparticles in human cervical mucus.

  2009cited by this paper
• Anti-HIV drugs: 25 compounds approved within 25 years after the discovery of HIV.

  2009cited by this paper
• Indinavir-Loaded pH-Sensitive Microparticles for Taste Masking: Toward Extemporaneous Pediatric Anti-HIV/AIDS Liquid Formulations with Improved Patient Compliance

  2009cited by this paper
• Intravaginal gene silencing using biodegradable polymer nanoparticles densely loaded with small-interfering RNA

  2009cited by this paper
• Development of a long-acting injectable formulation with nanoparticles of rilpivirine (TMC278) for HIV treatment.

  2009cited by this paper
• Differential Roles of P-Glycoprotein, Multidrug Resistance-Associated Protein 2, and CYP3A on Saquinavir Oral Absorption in Sprague-Dawley Rats

  2008cited by this paper
• Dendrimers as biopharmaceuticals: synthesis and properties.

  2008cited by this paper
• Electromagnetic interference in the permeability of saquinavir across the blood-brain barrier using nanoparticulate carriers.

  2008cited by this paper
• Advances in lipid nanodispersions for parenteral drug delivery and targeting.

  2008cited by this paper
• Polymeric Nanoparticles for Enhancing Antiretroviral Drug Therapy

  2008cited by this paper
• Antiretroviral drug-based microbicides to prevent HIV-1 sexual transmission.

  2008cited by this paper
• Interactions of pluronic block copolymers on P-gp efflux activity: experience with HIV-1 protease inhibitors.

  2008cited by this paper
• Characterization of carbosilane dendrimers as effective carriers of siRNA to HIV-infected lymphocytes.

  2008cited by this paper
• Polymeric micelles in oral chemotherapy.

  2008cited by this paper
• Cellular reservoirs of HIV-1 and their role in viral persistence.

  2008cited by this paper
• Cell-based drug delivery.

  2008cited by this paper
• Targeting of efavirenz loaded tuftsin conjugated poly(propyleneimine) dendrimers to HIV infected macrophages in vitro.

  2008cited by this paper
• Exploring the use of novel drug delivery systems for antiretroviral drugs.

  2008cited by this paper
• Pluronic block copolymers: evolution of drug delivery concept from inert nanocarriers to biological response modifiers.

  2008cited by this paper
• Disposition of Drugs in Block Copolymer Micelle Delivery Systems

  2008cited by this paper
• Permeability of surface-modified polyamidoamine (PAMAM) dendrimers across Caco-2 cell monolayers.

  2008cited by this paper
• Effects of Human Immunodeficiency Virus Protease Inhibitors on the Intestinal Absorption of Tenofovir Disoproxil Fumarate In Vitro

  2007cited by this paper
• Bioavailability and pharmacokinetic model for ritonavir in the rat.

  2007cited by this paper
• Targeting potential and anti-HIV activity of lamivudine loaded mannosylated poly (propyleneimine) dendrimer.

  2007cited by this paper
• HIV drug development: the next 25 years

  2007cited by this paper
• Laboratory investigations for the morphologic, pharmacokinetic, and anti-retroviral properties of indinavir nanoparticles in human monocyte-derived macrophages.

  2007cited by this paper
• Characterization of physico-chemical properties and pharmaceutical performance of sucrose co-freeze-dried solid nanoparticulate powders of the anti-HIV agent loviride prepared by media milling.

  2007cited by this paper
• Endocytosis and Interaction of Poly (Amidoamine) Dendrimers with Caco-2 Cells

  2007cited by this paper
• Rapid transport of large polymeric nanoparticles in fresh undiluted human mucus

  2007cited by this paper
• Novel Delivery System Enhances Efficacy of Antiretroviral Therapy in Animal Model for HIV-1 Encephalitis

  2007cited by this paper
• Poly(ethylene oxide)-poly(propylene oxide) block copolymer micelles as drug delivery agents: improved hydrosolubility, stability and bioavailability of drugs.

  2007cited by this paper
• Surface acetylation of polyamidoamine (PAMAM) dendrimers decreases cytotoxicity while maintaining membrane permeability.

  2007cited by this paper
• Selective transmission of CCR5-utilizing HIV-1: the 'gatekeeper' problem resolved?

  2006cited by this paper
• Micellar Nanocarriers: Pharmaceutical Perspectives

  2006cited by this paper
• Parameters influencing the stealthiness of colloidal drug delivery systems.

  2006cited by this paper
• Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles.

  2006cited by this paper
• Effect of nanoparticulate polybutylcyanoacrylate and methylmethacrylate-sulfopropylmethacrylate on the permeability of zidovudine and lamivudine across the in vitro blood-brain barrier.

  2006cited by this paper
• Transport of Poly(Amidoamine) Dendrimers across Caco-2 Cell Monolayers: Influence of Size, Charge and Fluorescent Labeling

  2006cited by this paper
• Atazanavir and lopinavir/ritonavir: pharmacokinetics, safety and efficacy of a promising double-boosted protease inhibitor regimen

  2006cited by this paper
• Experimental determination of the diffusion boundary layer width of micron and submicron particles.

  2006cited by this paper
• Intracellular Delivery of Saquinavir in Biodegradable Polymeric Nanoparticles for HIV/AIDS

  2006cited by this paper
• Influence of polyethylene glycol chain length on the physicochemical and biological properties of poly(ethylene imine)-graft-poly(ethylene glycol) block copolymer/SiRNA polyplexes.

  2006cited by this paper
• Therapeutic potential of nanoparticulate systems for macrophage targeting.

  2005cited by this paper
• Transepithelial and endothelial transport of poly (amidoamine) dendrimers.

  2005cited by this paper
• Erratum: Amphiphilic Block Copolymers for Drug Delivery

  2005cited by this paper
• Designing dendrimers for biological applications

  2005cited by this paper
• Atazanavir plus ritonavir or saquinavir, and lopinavir/ritonavir in patients experiencing multiple virological failures

  2005cited by this paper
• First clinical data on RNAi.

  2005cited by this paper
• ATAZANAVIR: EFFECTS ON P-GLYCOPROTEIN TRANSPORT AND CYP3A METABOLISM IN VITRO

  2005cited by this paper
• Block copolymer micelles as a solution for drug delivery problems

  2005cited by this paper
• The use of a dendrimer-propranolol prodrug to bypass efflux transporters and enhance oral bioavailability.

  2004cited by this paper
• In vitro and in vivo evaluation of a melamine dendrimer as a vehicle for drug delivery.

  2004cited by this paper
• The role of biopharmaceutics in the development of a clinical nanoparticle formulation of MK-0869: a Beagle dog model predicts improved bioavailability and diminished food effect on absorption in human.

  2004cited by this paper
• Comparative Effects on Intestinal Absorption in Situ by P-glycoprotein-Modifying HIV Protease Inhibitors

  2004cited by this paper
• Predicting Drug Disposition via Application of BCS: Transport/Absorption/ Elimination Interplay and Development of a Biopharmaceutics Drug Disposition Classification System

  2004cited by this paper
• Molecular properties of WHO essential drugs and provisional biopharmaceutical classification.

  2004cited by this paper
• Cytotoxicity, hemolysis, and acute in vivo toxicity of dendrimers based on melamine, candidate vehicles for drug delivery.

  2004cited by this paper
• The influence of surface modification on the cytotoxicity of PAMAM dendrimers.

  2003cited by this paper
• Transport mechanism(s) of poly (amidoamine) dendrimers across Caco-2 cell monolayers.

  2003cited by this paper
• Engineering of Dendrimer Surfaces to Enhance Transepithelial Transport and Reduce Cytotoxicity

  2003cited by this paper
• Nanosizing: a formulation approach for poorly-water-soluble compounds.

  2003cited by this paper
• Amphiphilic block copolymers for drug delivery.

  2003cited by this paper
• Influence of Surface Chemistry of Poly(Amidoamine) Dendrimers on Caco-2 Cell Monolayers

  2003cited by this paper
• Physical Characterization and Macrophage Cell Uptake of Mannan-Coated Nanoparticles

  2003cited by this paper
• Modulation of HIV-1 replication by RNA interference

  2002cited by this paper
• Open-label study of a twice-daily indinavir 800-mg/ritonavir 100-mg regimen in protease inhibitor-naive HIV-infected adults.

  2002cited by this paper
• Biopharmaceutics Classification System: The Scientific Basis for Biowaiver Extensions

  2002cited by this paper
• Transepithelial transport of poly(amidoamine) dendrimers across Caco-2 cell monolayers.

  2002cited by this paper
• Inhibition of retroviral pathogenesis by RNA interference.

  2002cited by this paper
• Inhibition of HIV-1 Infection by Small Interfering RNA-Mediated RNA Interference1

  2002cited by this paper
• P-glycoprotein limits oral availability, brain, and fetal penetration of saquinavir even with high doses of ritonavir.

  2001cited by this paper
• The macrophage in HIV infection.

  2001cited by this paper
• Nanosuspensions as particulate drug formulations in therapy. Rationale for development and what we can expect for the future.

  2001cited by this paper
• Structure and design of polymeric surfactant-based drug delivery systems.

  2001cited by this paper
• Sugar-installed block copolymer micelles: their preparation and specific interaction with lectin molecules.

  2001cited by this paper
• Long-circulating and target-specific nanoparticles: theory to practice.

  2001cited by this paper
• Pluronic P85 enhances the delivery of digoxin to the brain: in vitro and in vivo studies.

  2001cited by this paper
• Anionic PAMAM Dendrimers Rapidly Cross Adult Rat Intestine In Vitro: A Potential Oral Delivery System?

  2000cited by this paper
• Inhibition of Multidrug Resistance-Associated Protein (MRP) Functional Activity with Pluronic Block Copolymers

  1999cited by this paper
• Nano-engineering block copolymer aggregates for drug delivery

  1999cited by this paper
• Role of P-Glycoprotein on the CNS Disposition of Amprenavir (141W94), an HIV Protease Inhibitor

  1999cited by this paper
• Oral absorption of the HIV protease inhibitors: a current update.

  1999cited by this paper
• Pluronic P85 Increases Permeability of a Broad Spectrum of Drugs in Polarized BBMEC and Caco-2 Cell Monolayers

  1999cited by this paper
• Effects of Pluronic Block Copolymers on Drug Absorption in Caco-2 Cell Monolayers

  1998cited by this paper
• Body distribution of azidothymidine bound to hexyl-cyanoacrylate nanoparticles after i.v. injection to rats.

  1998cited by this paper
• The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors.

  1998cited by this paper
• Macrophages as a source of HIV during opportunistic infections.

  1997cited by this paper
• Hypersensitization of multidrug resistant human ovarian carcinoma cells by pluronic P85 block copolymer.

  1996cited by this paper
• Gastrointestinal Uptake of Biodegradable Microparticles: Effect of Particle Size

  1996cited by this paper
• Macrophage Targeting of Azidothymidine: A Promising Strategy for AIDS Therapy*

  1996cited by this paper

• Correction: Senceroglu et al. Constructing an Intelligent Model Based on Support Vector Regression to Simulate the Solubility of Drugs in Polymeric Media. Pharmaceuticals 2022, 15, 1405

  2026cites this paper
• Polymeric and lipidic nanoparticles in transforming anti-HIV combinational therapy: can they turn the tide?

  2025cites this paper
• Unlocking ginsenosides’ therapeutic power with polymer-based delivery systems: current applications and future perspectives

  2025cites this paper
• Co-amorphous Approach for Enhancing Rilpivirine Oral Bioavailability using CYP3A4 Inhibitor as a Co-former

  2025cites this paper
• Surfactant-based drug delivery strategies for HIV/AIDS therapy: advances in formulation and clinical translation

  2025cites this paper
• Formulation Development and In-Vitro Assessment of Rilpivirine Nanobilosomes

  2024cites this paper
• Development and characterization of co-amorphous griseofulvin/L-leucin by modified solvent processing hot-melt extrusion.

  2024cites this paper
• Nanotechnological innovations in paediatric tuberculosis management: current trends and future prospects

  2024cites this paper
• Nanovesicles as Potential Carriers for Delivery of Antiviral Drugs: A Comprehensive Review

  2024cites this paper
• Application of Design of Experiment in the Optimization of Apixaban-Loaded Solid Lipid Nanoparticles: In Vitro and In Vivo Evaluation

  2023cites this paper
• Envisioning the prospect of nanocarriers as an effective management tool against NeuroAIDS

  2023cites this paper
• Apigenin-Loaded Stealth Liposomes: Development and Pharmacokinetic Studies for Enhanced Plasma Retention of Drug in Cancer Therapy

  2023cites this paper
• The multifaceted role of pectin in keratin based nanocomposite with antimicrobial and anti-oxidant activity

  2022cites this paper
• Bioavailability Enhancement of Vitamin E TPGS Coated Liposomes of Nintedanib Esylate Formulation Developed Using Quality by Design Approach

  2022cites this paper
• Application of Sol–Gels for Treatment of Gynaecological Conditions—Physiological Perspectives and Emerging Concepts in Intravaginal Drug Delivery

  2022cites this paper
• Nanoparticle-based strategies to target HIV-infected cells.

  2022cites this paper
• Constructing an Intelligent Model Based on Support Vector Regression to Simulate the Solubility of Drugs in Polymeric Media

  2022cites this paper
• Progress on Applying Carbon Dots for Inhibition of RNA Virus Infection

  2022cites this paper
• Lopinavir-Loaded Self-Nanoemulsifying Drug Delivery System for Enhanced Solubility: Development, Characterisation and Caco-2 Cell Uptake.

  2022cites this paper
• Development and Evaluation of Nanosuspension of Albendazole by Nanoprecipitation

  2022cites this paper
• Nanopharmaceuticals: Principles and Applications Vol. 2

  2021cites this paper
• Polycaprolactone and polycaprolactone triol blends to obtain a stable liquid nanotechnological formulation: synthesis, characterization and in vitro – in vivo taste masking evaluation

  2021cites this paper
• Particular Aspects on Applying Nanocarbon Quantum Dots for HIV Inhibition and Theranostics: a Review

  2021cites this paper
• Advances in Nanomaterials-Based Carrier System for the Treatment of Breast Cancer

  2021cites this paper
• Nanosuspension a Promising Tool for Solubility Enhancement: A Review

  2021cites this paper
• Nanocomposites: Potential therapeutic agents for the diagnosis and treatment of infectious diseases and cancer

  2021cites this paper
• Improvement of Drug Delivery Properties of Risperidone via Preparation of Fast Dissolution Tablet Containing Nanostructured Microparticles

  2021cites this paper
• Nanomedicine based approaches for combating viral infections.

  2021cites this paper
• Nanotechnology Based Drug Delivery for HIV-AIDS Treatment

  2021cites this paper
• New Perspectives in Drug Delivery Systems for the Treatment of Tuberculosis.

  2021cites this paper
• Multi-organ Targeting of HIV-1 Viral Reservoirs with Etravirine Loaded Nanostructured Lipid Carrier: An In-vivo Proof of Concept.

  2021cites this paper
• Improving the bioavailability and bioactivity of garlic bioactive compounds via nanotechnology

  2021cites this paper
• Nanosuspension as Promising and Potential Drug Delivery: A Review

  2021cites this paper
• Management of Antiretroviral Therapy with Boosted Protease Inhibitors—Darunavir/Ritonavir or Darunavir/Cobicistat

  2021cites this paper
• Development and Characterization of Venetoclax Nanocrystals for Oral Bioavailability Enhancement

  2021cites this paper
• An in-depth analysis of novel combinatorial drug therapy via nanocarriers against HIV/AIDS infection and their clinical perspectives: a systematic review

  2021cites this paper
• Controlled solvent removal from antiviral drugs and excipients in solution enables the formation of novel combination multi-drug-motifs in pharmaceutical powders composed of lopinavir, ritonavir and tenofovir.

  2020cites this paper
• Polyethylene glycol (5,000) succinate conjugate of lopinavir and its associated toxicity using Danio rerio as a model organism

  2020cites this paper
• Enhancing Betulinic Acid Dissolution Rate and Improving Antitumor Activity via Nanosuspension Constructed by Anti-Solvent Technique

  2020cites this paper
• Enhancing Betulinic Acid Dissolution Rate and Improving Antitumor Activity via Nanosuspension Constructed by Anti-Solvent Technique

  2020cites this paper
• Nanocarriers as Tools for Delivery of Nature Derived Compounds and Extracts with Therapeutic Activity

  2020cites this paper
• Functionalised Dendrimers: Potential Tool for Antiretroviral Therapy

  2020cites this paper
• Enhancing Betulinic Acid Dissolution Rate and Improving Antitumor Activity via Nanosuspension Constructed by Anti-Solvent Technique

  2020cites this paper
• Biological Aspects and Clinical Applications of Nanoparticles on Treatment and Prophylaxis of HIV

  2020cites this paper
• Mucoadhesive nanocrystal-in-microspheres with high drug loading capacity for bioavailability enhancement of silybin.

  2020cites this paper
• Nanotechnology: A Curative Approach to Combat HIV-AIDS

  2020cites this paper
• Nanopharmaceuticals: Healthcare Applications and Safety Evaluations

  2020cites this paper
• The elucidation of key factors for oral absorption enhancement of nanocrystal formulations: In vitro - in vivo correlation of nanocrystals.

  2019cites this paper
• Engineered Nanomaterials as Potential Candidates for HIV Treatment: Between Opportunities and Challenges

  2019cites this paper
• Drug nanocrystals: Fabrication methods and promising therapeutic applications.

  2019cites this paper
• Nucleic Acid-Based Nanocarriers

  2019cites this paper
• Freeze-Dried Lopinavir-Loaded Nanostructured Lipid Carriers for Enhanced Cellular Uptake and Bioavailability: Statistical Optimization, in Vitro and in Vivo Evaluations

  2019influential citation
• Insights on Oral Drug Delivery of Lipid Nanocarriers: a Win-Win Solution for Augmenting Bioavailability of Antiretroviral Drugs

  2019cites this paper
• Nanotechnology approaches to eradicating HIV reservoirs

  2019cites this paper
• Synergistic Nanoparticle Formulations against Multi-drug Resistant Breast Cancers

  2019cites this paper
• FORMULATION DEVELOPMENT AND DISSOLUTION RATE ENHANCEMENT OF RILPIVIRINE BY SOLID DISPERSION SYSTEMS

  2019cites this paper
• Submission of Rifaximin to Different Techniques: Characterization, Solubility Study, and Microbiological Evaluation

  2019cites this paper
• Development Of Saquinavir Mesylate Nanoemulsion-Loaded Transdermal Films: Two-Step Optimization Of Permeation Parameters, Characterization, And Ex Vivo And In Vivo Evaluation

  2019cites this paper
• Nanoparticle-in-microparticle oral drug delivery system of a clinically relevant darunavir/ritonavir antiretroviral combination.

  2018cites this paper
• Investigation of Cyclodextrin-Based Nanosponges for Solubility and Bioavailability Enhancement of Rilpivirine

  2018cites this paper
• Honokiol nanoparticles based on epigallocatechin gallate functionalized chitin to enhance therapeutic effects against liver cancer

  2018cites this paper
• 16 Dendrimers in Anti-HIV Therapy

  2018cites this paper
• Development of PLGA nanoparticles loaded with clofazimine for oral delivery: Assessment of formulation variables and intestinal permeability

  2018cites this paper
• Drug Micro-Carriers Based on Polymers and Their Sterilization

  2018cites this paper
• Synthesis and characterization of a new cyclodextrin derivative with improved properties to design oral dosage forms

  2018cites this paper
• pH-responsive biomaterials for smart intravaginal drug delivery

  2018cites this paper
• Design and in vivo pharmacokinetic study of a newly developed lamivudine transdermal patch

  2018cites this paper
• Engineered polymeric nanoparticles to guide the cellular internalization and trafficking of small interfering ribonucleic acids

  2017cites this paper
• Application of nanotechnology for the development of microbicides

  2017cites this paper
• Nanocrystal formulations of a poorly soluble drug. 1. In vitro characterization of stability, stabilizer adsorption and uptake in liver cells.

  2017cites this paper
• Improvement of Oral Bioavailability of Lopinavir Without Co-administration of Ritonavir Using Microspheres of Thiolated Xyloglucan

  2017cites this paper
• BCS class IV drugs: Highly notorious candidates for formulation development

  2017cites this paper
• Multidrug, Anti-HIV Amorphous Solid Dispersions: Nature and Mechanisms of Impacts of Drugs on Each Other's Solution Concentrations.

  2017cites this paper
• Chapter 9 Pluronic Nanotechnology for Overcoming Drug Resistance

  2017cites this paper
• Self-assembled nanoparticles made from a new PEGylated poly(aspartic acid) graft copolymer for intravaginal delivery of poorly water-soluble drugs

  2017cites this paper
• Improving health-care delivery in low-resource settings with nanotechnology

  2017cites this paper
• Pluronic Nanotechnology for Overcoming Drug Resistance

  2017cites this paper
• Chapter 10 Dissolution of Nanoparticle Drug Formulations

  2017cites this paper
• Enhanced dissolution of poorly soluble antiviral drugs from nanoparticles of cellulose acetate based solid dispersion matrices

  2017cites this paper
• Formulation Development and Optimization of Nanosuspension of Simvastatin for Improved Solubility by Nanomilling

  2016cites this paper
• Engineered nanoparticles of Efavirenz using methacrylate co-polymer (Eudragit-E100) and its biological effects in-vivo.

  2016cites this paper
• Development of peptide inhibitors of HIV transmission

  2016cites this paper
• Nano-ART and NeuroAIDS

  2016cites this paper
• Neurotoxicity in the Post-HAART Era: Caution for the Antiretroviral Therapeutics

  2016cites this paper
• Fungal Nanoparticles: An Emerging Tool in Medical Biology

  2016cites this paper
• Chitosan Nanoparticles Prepared by Ionotropic Gelation: An Overview of Recent Advances.

  2016cites this paper
• Preparation and characterization of nanoparticles of carboxymethyl cellulose acetate butyrate containing acyclovir

  2016cites this paper
• Improving combination antiretroviral therapy by targeting HIV-1 gene transcription

  2016cites this paper
• A combined TD-DFT and spectroscopic investigation of the solute-solvent interactions of efavirenz.

  2016cites this paper
• Challenges in oral drug delivery of antiretrovirals and the innovative strategies to overcome them.

  2016cites this paper
• Drug Optimization: Fighting Research to Achieve the Greatest Use of Darunavir

  2016cites this paper
• Non-Sink Dissolution Conditions for Predicting Product Quality and In Vivo Performance of Supersaturating Drug Delivery Systems.

  2016cites this paper
• Formulation and optimization of Eudragit RS PO-tenofovir nanocarriers using Box-Behnken experimental design

  2015cites this paper
• Nanotechnology: A magic bullet for HIV AIDS treatment

  2015cites this paper
• Production and characterization of composite nano/micro sized particles by rapid expansion of supercritical solutions (ress) co-precipitation

  2015cites this paper
• Diagnosis , Treatment and Prophylaxis of Aids

  2015cites this paper
• Nanoformulation strategies for the enhanced oral bioavailability of antiretroviral therapeutics.

  2015cites this paper
• Design, optimization and evaluation of poly-ɛ-caprolactone (PCL) based polymeric nanoparticles for oral delivery of lopinavir

  2015cites this paper
• Nanostructured Delivery Systems: Augmenting the Delivery of Antiretroviral Drugs for Better Management of HIV/AIDS.

  2015cites this paper
• Preparation and characterization of rilpivirine solid dispersions with the application of enhanced solubility and dissolution rate

  2015cites this paper